Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.
Jain
A
A
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania, USA.
Reyes
J
J
Kashyap
R
R
Rohal
S
S
Cacclarelli
T
T
McMichael
J
J
Rakela
J
J
Starzl
T E
TE
Fung
J J
JJ
D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D011183:Postoperative Complications / Q000453:epidemiology*; D011241:Prednisone / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D003404:Creatinine; D011241:Prednisone; D016559:Tacrolimus